ScreenerHero

IDX Integral Diagnostics Limited

ASX · AU · Healthcare · Biotechnology · integraldiagnostics.com.au
—Mkt Cap: —P/E: —

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, allied health professionals, and patients in Australia and New Zealand. It …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.87BUSDP/E 29.6
MRNA
Moderna, Inc.
$94.42BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$81.99BUSDP/E 19.1
ARGX
argenx SE
$53.47BUSDP/E 32.5
ARGX
argenx SE
$53.22BUSDP/E 31.6
UCB
UCB SA
$44.02BUSDP/E 17.8
ONC
BeOne Medicines AG
$42.56BUSDP/E 66.4
RVMD
Revolution Medicines, Inc.
$40.57BUSD
RPRX
Royalty Pharma plc
$34.45BUSDP/E 30.4
ALNY
Alnylam Pharmaceuticals, Inc.
$31.32BUSDP/E 39.3
ROIV
Roivant Sciences Ltd.
$24.59BUSD
GMAB
Genmab A/S
$23.32BUSDP/E 31.7
GMAB
Genmab A/S
$23.26BUSDP/E 29.8
INCY
Incyte Corporation
$22.96BUSDP/E 14.0
BNTX
BioNTech SE
$22.66BUSD
INSM
Insmed Incorporated
$21.67BUSD
EXEL
Exelixis, Inc.
$15.57BUSDP/E 19.3
ASND
Ascendis Pharma A/S
$14.91BUSDP/E 17.4
JAZZ
Jazz Pharmaceuticals plc
$13.92BUSDP/E 14.7
HALO
Halozyme Therapeutics, Inc.
$13.79BUSDP/E 33.4

Key Statistics

Company
Market Cap—
Enterprise Value924.18M USD
Revenue (TTM)545.00M USD
Gross Profit520.16M USD
Net Income (TTM)15.16M USD
Revenue/Share2.12 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees3.0K
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU000000IDX2
Valuation
P/E (Trailing)—
P/E (Forward)13.62
PEG—
EV/EBITDA11.90
EV/Revenue1.70
P/S1.00
P/B1.17
EPS (TTM)0.06
EPS (Forward)0.16
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin95.44%
Oper. Margin10.26%
EBITDA Margin14.25%
Profit Margin2.78%
ROE3.24%
ROA1.54%
Growth
Revenue Growth5.60%
Earnings Growth303.70%
Cash Flow & Leverage
Operating CF65.82M USD
CapEx (TTM)34.31M USD
FCF Margin6.79%
FCF Yield—
Net Debt377.20M USD
Net Debt/EBITDA4.86
Balance Sheet
Debt/Equity0.88
Current Ratio0.67
Quick Ratio0.58
Book Value/Sh1.81 AUD
Cash/Share0.14 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.09 AUD
Div. Yield4.43%
5Y Avg Yield2.48%
Payout Ratio125.86%
Ex-Div DateAug 28, 2026
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2.989 AUD
Target Range2.240 AUD – 3.700 AUD
# Analysts13
Ownership
Shares Out.373.70M
Float339.29M
Insiders4.88%
Institutions49.22%
Technical
SMA 502.238 AUD
SMA 2002.260 AUD
Beta0.18
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)588.91K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—